CLOSE
Enter Website

Our site stores cookies on your computer. These cookies are used to offer more personalised services and improve each day. Continuing to browse our site implies acceptance of our cookie policy. See our legal notes or Close

_01

Expertise Line

API

In our production sites we mill a broad range of drug substances in multipurpose equipment with proven experience.

HPAPI

We are equipped with containment solutions (Glove- and Half Suit Boxes) to mill highly potent ingredients.

STEROID

This product category can be processed thanks to dedicated micronization lines.

FOOD & EXCIPIENT

In our production sites, excipients are milled in GMP equipment. The food ingredients are processed in dedicated lines with the same standard we are used to apply to pharmaceuticals.

NEW FRONTIERS

For more than 40 years, never ceasing to invest in research and in new contents on Micronization, in a much wider and integrated approach, has always been the sense of our job. Understanding and discerning evolving needs is a foremost task for a company providing services like ours.

_02

Service Line

PROCESS DEVELOPMENT

we offer our expertise to develop robust processes through DoE studies.

JET-, PIN- AND HAMMER MILLING

We provide to our customers micronization and milling services with a deep experience in the particle size reduction.

CO-MICRONIZATION

The simultaneous micronization of at least two compounds improves powder properties and skip potential blending steps.

MICRONIZATION UNDER CONTAINMENT

We are equipped with containment isolators, as part of a systematic approach to control the safe handling for potent compound.

POST MILLING CONDITIONING

With product conditioning we are able to resolve post micronization morphological issues.

QUALITY BY DESIGN

Before the Process Validation activity, we support our customers with an approach to QbD by the identification of the Critical Process Parameters (CPP), to be studied during the following Design of Experiment (DoE) development step.

CRYOGENIC MICRONIZATION

We provide to our customers particle size reduction by jet milling to very low temperature, for those compounds with a low brittleness and tacky, elastic polymers or semi-solid in nature. It is also used to prevent the degradation of highly sensitive products, to avoid polymorphic changes and to avoid any increase in amorphous particles.

ANALYTICAL SERVICES

We provide services for PSD analysis and related activities as method development, method validation, method transfer, etc. with our cutting-edge equipment.

NEW CLIENT’S NEEDS

Over time, our customers have requested newer and newer services depending on the market complexity. We have always worked embracing a concept of recognition and acceptance of Problem Solving, in a broad and factual sense. We have often been innovators in found and implemented solutions.

_03

Strategy Line

CONFIDENTIALITY

We guarantee a full confidentiality to our customers which rely on us as part of the development of new compounds.

INDEPENDENCE

The company, firmly in the hands of the founder’s second generation, continues along the path of complete independence able to ensure flexibility and avoid any conflict of interest towards its clients.

BUSINESS CONTINUITY PLAN

We ensure our customers having created a system of prevention and recovery from potential threats to the company.

ADVISORY SUPPORT

We accompany our clients with expertise, supporting them with regular consulting services for each step of the projects.

PARTNERSHIP

We consider our expertise and experience as basic concept for a long-lasting partnership with our customers.

INDEPENDENCE CONSOLIDATION

The milestones of our company philosophy are firmly pursued by the second generation and among them the guarantee of stability and business continuity. Elements that ensure flexibility, the respect of privacy and confidentiality of our whole profession.

_04

Key Factor

Proprietary Technology

We constantly improve the technology of our in-house designed mills which generates a precise scalability and maximizes the micronization yields

LEAD TIME

We provide a smart management of the projects evaluating the overall duration of the critical path in order to save time by accomplish customer´s needs.

FLEXIBILITY

We accommodate the needs of our customers adapting the day-to-day shifts with the willingness and ability to readily respond to changing circumstances and expectations.

R&D

We support our customers in their R&D process with our knowledge in particle size engeeneering

DOUBLING PRODUCTION CAPACITY

We have arranged a significant investment plan in our production sites that will entrain the doubling of our production and Micronization capacity. This decision was made to guarantee better and more performing lead times toward a market demanding such an expertise.

News

26 March 2021
2021 Formulation & Delivery Europe Online

MUNIT has announced it will be participating at the Formulation & Delivery Europe: Online Edition. The event will take place from 20 – 21 April 2021 and includes: Over 500 pharmaceutical scientists working across formulation, drug delivery and drug product manufacturing science & technologies, representing global pharmaceutical organisations, leading biotechnology companies and internationally-renowned academic institutions; …

5 March 2021
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

MUNIT has announced that it will soon participate in the following event: 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (11-14 May 2021) In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology …

Respiratory Drug Delivery 2021

MUNIT has announced that it will soon participate in the following event: Respiratory Drug Delivery 2021 (RDD 2021) Europe (04-07 May 2021) Respiratory Drug Delivery 2021 (RDD 2021) is the must attend, premier international conference for researchers, regulators, business professionals and suppliers active in pulmonary and nasal drug delivery. While the global pandemic is keeping …

6th Annual Highly Potent Active Pharmaceutical Ingredients Online Summit

MUNIT has announced that it will soon participate in the following events: 6th Annual Highly Potent Active Pharmaceutical Ingredients Online Summit (10-11 March 2021) This event will enable the participants to learn about the latest developments in the HPAPI Industry. This Summit will be focusing on latest market development trends in the highly potent active …

Jetpharma

 

Mr. Maurizio Schiavazzi

Chief Commercial Officer

mschiavazzi(a)munit.com

Jetpharma

 

Mr. Giovanni Frigerio

Chief Scientific Officer

gfrigerio(a)munit.com

Jetpharma

 

Ms. Katia Zocca

Customer Care

kzocca(a)munit.com

Jetpharma

 

Mr. Uwe Heidenreich

Business Development Manager

uheidenreich(a)munit.com

Jetpharma

 

Mr. Massimo Dal Bosco

Business Development Manager

mdalbosco(a)munit.com

Jetpharma

MUNIT SA
Via Crocicchio Cortogna 6
CH-6900 Lugano

Jetpharma

T. +41 (0)91 910 30 80

Jetpharma

contact(at)munit.com